QQ客服 官方微博 反馈留言

	Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer
	Wu, Yi-Long; Lu, Shun; Lu, You; Zhou, Jianying; Shi, Yuan-kai; Sriuranpong, Virote; Ho, James C. M.; Ong, Choo Khoon; Tsai, Chun-Ming; Chung, Chin-Hee
刊名	JOURNAL OF THORACIC ONCOLOGY
	2018
卷号	Vol.13 No.10页码:1539-1548
关键词	ALK-positive advanced non-small cell lung cancer crizotinib chemotherapy phase III
ISSN号	1556-0864
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1834378
专题	四川大学
作者单位	1.Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China 2.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Resp Dept, Hangzhou, Zhejiang, Peoples R China 3.Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Canc Ctr, Shanghai, Peoples R China 4.Sichuan Univ, West China Hosp, Dept Thorac Oncol, Chengdu, Sichuan, Peoples R China 5.Hosp Pulau Pinang, Dept Resp Med, George Town, Malaysia 6.Guangdong Acad Med Sci, 7.Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China 8.Pfizer Oncol, La Jolla, CA USA 9.King Chulalongkorn Mem Hosp, Bangkok, Thailand 10.Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan
推荐引用方式 GB/T 7714	Wu, Yi-Long,Lu, Shun,Lu, You,et al. Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer[J]. JOURNAL OF THORACIC ONCOLOGY,2018,Vol.13 No.10:1539-1548.
APA	Wu, Yi-Long.,Lu, Shun.,Lu, You.,Zhou, Jianying.,Shi, Yuan-kai.,...&Chung, Chin-Hee.(2018).Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.JOURNAL OF THORACIC ONCOLOGY,Vol.13 No.10,1539-1548.
MLA	Wu, Yi-Long,et al."Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer".JOURNAL OF THORACIC ONCOLOGY Vol.13 No.10(2018):1539-1548.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。